In what should come as no surprise to anyone who knows the effects of smoking on patients with asthma, a new report indicates that the latest strings of indoor smoking bans will have a direct impact on reducing emergency room visits due to asthma attacks. Basically, it proves that not subjecting children with breathing problems to tobacco smog is good for their health.
The study was done by researchers at the University of Chicago Medicine, Tech Times reports, and their findings indicate that the ban on smoking indoors results in the drastic reduction of asthma attacks among children that lead to emergency room visits. Three years after the ban was put in effect, ER visits were reduced by 17 percent.
Christina Ciaccio is an expert in pediatric allergy and along with her team, they looked into the emergency room records of over 20 cities where indoor smoking has been banned. After looking at their records from 2000 until 2014, the researchers noted a definite decrease in overall ER visits prompted by breathing problems among asthmatic patients.
This isn’t really surprising since air pollution of any kind has been a major hazard for the 6.3 million American children with asthma living in the U.S. alone. To be fair, other causes of asthma attacks can include everything from car exhaust, factory smoke, allergens, dust, and the occasional overexertion when the weather is cold.
However, as far as causes that induce attacks indoors go, smoking is cited as one of the leading factors, hence the ban. Then again, the researchers themselves acknowledge that their findings are not entirely foolproof since there are some fluctuations in data, MedicalXpress reports. For now, the results of the study simply show that the legislative action pertaining to the smoking ban has a significant impact on public health.


Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



